A multicenter randomized trial in The Lancet Regional Health – Western Pacific found that sitafloxacin monotherapy is non-inferior to standard doxycycline–rifampicin combination therapy for acute uncomplicated brucellosis, with a superior safety and tolerability profile. This finding may simplify treatment and improve patient adherence in endemic regions. — Photo by Thirdman on Pexels (Pexels License)
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.
